Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-133667
Filing Date
2024-12-05
Accepted
2024-12-05 16:05:05
Documents
2
Period of Report
2024-12-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1551
2 EX-24 omga-ex24.htm EX-24 16366
  Complete submission text file 0000950170-24-133667.txt   19378
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OMEGA THERAPEUTICS, INC. 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address
Mehrotra Ravi (Reporting) CIK: 0002047027 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40657 | Film No.: 241529096